3
Shared Docs
3
Same-Page
5 / 3
Mentions
spected of having Clostridium difficile associated disease. This is the third test from IMDx to receive FDA clearance within three months for use on Abbott's fully-automatedm2000 system and follows clearances of the IMDx VanR for Abbott m2000 and IMDx Flu A/B and RSV for Abbott m2000 assays. C. diffici
f a successful move into our new corporate headquarters in Waltham, MA, IMDx today announced its third FDA clearance for its C. difficile assay for Abbott m2000 assay. My best, Alice IntelligentMDx Receives FDA Clearance for IMDx C. difficile for Abbott m2000 Assay, Completes Move of Corporate Headq
From: Alice Jacobs Nesselrodt :< => To: Alice Jacobs Nesselrodt Subject: IMDx receives 3rd FDA clearance and relocates HQ to Waltham Date: Tue, 12 Nov 2013 21:14:41 +0000 Atta
From: Alice Jacobs <I To: Denise Marston <I CC: Denise Marston <I Subject: MDx Receives FDA Clearance for IMDx VanR for Abbott m2000 assay Date: Tue, 30 Jul 2013 14:40:22 +0000 Attachments: IMDx VanR for Abbott m2000 FDA clearance_.pdf I hope you are doing well and are hav
rston <I Subject: MDx Receives FDA Clearance for IMDx VanR for Abbott m2000 assay Date: Tue, 30 Jul 2013 14:40:22 +0000 Attachments: IMDx VanR for Abbott m2000 FDA clearance_.pdf I hope you are doing well and are having a great summer. I am pleased to announce that IMDx has achieved a pivotal milesto
t IMDx can offer a diagnostic solution to aid in the identification of vancomycin-resistant colonization in hospital settings in the U.S.," says Dr. Alice Jacobs Nesselrodt, Chairman and CEO of IMDx. "FDA clearance of the IMDx VanR for Abbott m2000 assay is a step toward the fulfillment of IMDx's mission to make clinic
EN — the QIAGEN artus C. difficile QS-RGQ MDx Kit. This is the fourth FDA clearance in less than a year for IMDx (3 FDA clearances were obtained for Abbott kits). In April, the FDA cleared the QIAGEN artus C. difficile QS-RGQ MDx Kit, developed and manufactured by IMDx, for use on the QIAGEN QlAsymphony
From: Alice Jacobs Nesselrodt To: Alice Jacobs Nesselrodt Subject: IMDx achieves 4th FDA clearance--QIAGEN anus C difficile QS-RGQ MDx--a test for a serious healthcare-associated
Entities connected to both Abbott and Alice Jacobs Nesselrodt